Transfusion of HIV-infected blood products despite highly sensitive nucleic acid testing-Reference-Cited by-同舟云学术

Transfusion of HIV-infected blood products despite highly sensitive nucleic acid testing

Published:2019-02-19 Issue:6 Volume:59 Page:2046-2053
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Cappy Pierre¹^ORCID,Barlet Valérie²,Lucas Quentin¹,Tinard Xavier³,Pillonel Josiane⁴,Gross Sylvie⁵,Tiberghien Pierre⁵⁶,Laperche Syria¹

Affiliation:

1. Département des Agents Transmissibles par le Sang, Centre National de Référence Risques Infectieux Transfusionnels; Institut National de la Transfusion Sanguine (INTS); Paris France

2. ETS Auvergne Rhône Alpes, Laboratoire de qualification biologique des dons Est; Etablissement Français du Sang; Metz-Tessy France

3. ETS grand est, Pôle des vigilances; Etablissement Français du Sang; Nancy France

4. Département des maladies infectieuses; Santé publique France; Saint-Maurice France

5. Etablissement Français du Sang; Saint Denis France

6. Unité mixte de recherche 1098 INSERM; Université de Franche-Comté, Etablissement Français du Sang; Besançon France

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/trf.15203/fullpdf

Reference47 articles.

1. International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009;Roth;Vox Sang,2012

2. Sensitivity of two hepatitis B virus, hepatitis C virus (HCV), and human immunodeficiency virus (HIV) nucleic acid test systems relative to hepatitis B surface antigen, anti-HCV, anti-HIV, and p24/anti-HIV combination assays in seroconversion panels;Assal;Transfusion,2009

3. Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus;Seed;Intern Med J,2005

4. Donor testing and risk: current prevalence, incidence, and residual risk of transfusion-transmissible agents in US allogeneic donations;Zou;Transfus Med Rev,2012

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of recent criteria changes for the deferral criteria specific to men who have sex with men in France;Vox Sanguinis;2024-09

2. Implementation of amotosalen plus ultraviolet A‐mediated pathogen reduction for all platelet concentrates in France: Impact on the risk of transfusion‐transmitted infections;Vox Sanguinis;2023-12-28

3. Human immunodeficiency virus, hepatitis C virus and hepatitis B virus incidence in blood donors from 2000 to 2020 in France: Trends and lessons from haemovigilance surveillance;Vox Sanguinis;2023-09-11

4. Assessment of the impact of pathogen reduction technologies on the neutralizing activity of COVID-19 convalescent plasma.;Transfusion and Apheresis Science;2023-06

5. Modeling the Risk of HIV Transfusion Transmission;JAIDS Journal of Acquired Immune Deficiency Syndromes;2023-02-01